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and outcome in intensive care patients with
faecal peritonitis: analysis of the GenOSept cohort
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GenOSept InvestigatorsAbstract
Introduction: Patients admitted to intensive care following surgery for faecal peritonitis present particular
challenges in terms of clinical management and risk assessment. Collaborating surgical and intensive care teams
need shared perspectives on prognosis. We aimed to determine the relationship between dynamic assessment of
trends in selected variables and outcomes.
Methods: We analysed trends in physiological and laboratory variables during the first week of intensive care unit
(ICU) stay in 977 patients at 102 centres across 16 European countries. The primary outcome was 6-month
mortality. Secondary endpoints were ICU, hospital and 28-day mortality. For each trend, Cox proportional hazards
(PH) regression analyses, adjusted for age and sex, were performed for each endpoint.
Results: Trends over the first 7 days of the ICU stay independently associated with 6-month mortality were worsening
thrombocytopaenia (mortality: hazard ratio (HR) = 1.02; 95% confidence interval (CI), 1.01 to 1.03; P <0.001) and renal
function (total daily urine output: HR =1.02; 95% CI, 1.01 to 1.03; P <0.001; Sequential Organ Failure Assessment (SOFA)
renal subscore: HR = 0.87; 95% CI, 0.75 to 0.99; P = 0.047), maximum bilirubin level (HR = 0.99; 95% CI, 0.99 to 0.99; P = 0.02)
and Glasgow Coma Scale (GCS) SOFA subscore (HR = 0.81; 95% CI, 0.68 to 0.98; P = 0.028). Changes in renal function
(total daily urine output and renal component of the SOFA score), GCS component of the SOFA score, total SOFA score
and worsening thrombocytopaenia were also independently associated with secondary outcomes (ICU, hospital and
28-day mortality). We detected the same pattern when we analysed trends on days 2, 3 and 5. Dynamic trends in all
other measured laboratory and physiological variables, and in radiological findings, changes inrespiratory support, renal
replacement therapy and inotrope and/or vasopressor requirements failed to be retained as independently associated
with outcome in multivariate analysis.
Conclusions: Only deterioration in renal function, thrombocytopaenia and SOFA score over the first 2, 3, 5 and 7 days
of the ICU stay were consistently associated with mortality at all endpoints. These findings may help to inform clinical
decision making in patients with this common cause of critical illness.* Correspondence: ascanio.tridente@doctors.org.uk
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Patients admitted to intensive care following surgery for
faecal peritonitis (FP) present particular challenges in
terms of clinical management and risk assessment. Col-
laborating surgical and intensive care teams need shared
perspectives on trends in illness severity and likely out-
comes. Dynamic assessment of trends and the response
to treatment, including evaluation of changes in labora-
tory tests and dependence on organ support, may be
more informative than isolated initial measurements
when assessing the prognosis of individual patients. Sev-
eral methods have been evaluated for dynamic assessment
of critically ill patients [1-4], including those undergoing
surgery, and some researchers have examined dynamic
changes in patients with peritonitis [5-9]. The burden of
data collection is considered by many to be a deterrent to
routine use [10], however, and one study found that exist-
ing scoring systems were inadequate for this purpose [9].
These studies were relatively small, though; the largest
reported data on 163 patients only.
Given the paucity of data on the association between
trends in clinical variables during the early stages of inten-
sive care unit (ICU) admission following surgical interven-
tion for FP and outcomes, we used a large international
database of patients with FP with the aim of analysing
trends in all available clinical variables during the first
week of ICU stay and their relationship to outcome.
Intraabdominal infections, and in particular FP,
although affecting all age groups, are conditions which
typically affect the elderly. The severity of sepsis and the
likelihood of an adverse outcome are both reflected in
persisting organ system failures and may be aggravated
by limited physiologic reserve, the presence of comor-
bidities and impaired wound healing [11,12]. With an
ageing population, the incidence of FP is likely to
increase, adding pressure on already scarce health care
resources [13,14]. In this setting, detecting trends in key
laboratory and physiological variables and in the severity
of organ dysfunction could prove useful in supporting
decision making with regard to escalating, limiting or
withdrawing treatment, and it might help reduce vari-
ability in critical care decision making [15].
The Genetics of Sepsis and Septic Shock in Europe
(GenOSept) trial is a pan-European study funded by the
Sixth Framework Programme of the European Union. It
was conceived by the European Critical Care Research
Network of the European Society for Intensive Care
Medicine to investigate the potential impact of genetic
variation on the host response and outcomes in sepsis
[16]. To date, the GenOSept cohort includes the largest
and diagnostically most homogeneous collection of
clinical data on critically ill patients with FP. We
recently reported outcome analyses of this cohort, based
on data from day 1 of admission to the ICU [12].Material and methods
Recruitment and ethical approval
Ethical approval was granted either nationally and/or
locally (for individual centres—see Additional file 1).
Written informed consent for inclusion in the GenOSept
study was obtained from all patients or their legal
representatives. The study was performed in accordance
with the ethical standards laid down in the 1964
Declaration of Helsinki and its later amendments. Patients
were recruited from 102 centres across 16 European
countries (see Additional file 1 for contributors) between
September 2005 and January 2011.
The definition of sepsis was based on the International
Consensus Criteria as “the clinical syndrome defined by
the presence of both infection and a systemic inflamma-
tory response” ([17], p 532). Patients were followed for
up to 6 months from enrolment or until death.
To be included, patients had to be adults (>18 years)
admitted to a high-dependency unit or ICU with FP. FP
was defined as inflammation of the serosal membrane
that lines the abdominal cavity, secondary to contamin-
ation by faeces, as diagnosed at laparotomy.
Exclusion criteria were peritonitis due to gastric or
upper gastrointestinal tract perforation (for example,
gastric or duodenal ulcer perforation, terminal ileum
perforation); patient or patient’s legal representative un-
willing or unable to give consent; patient pregnant; ad-
vanced directive to withhold or withdraw life-sustaining
treatment or admitted for palliative care only; patient
already enrolled in an interventional research study of a
novel and/or unlicensed therapy (patients enrolled in
interventional studies examining the clinical application
or therapeutic effects of widely accepted, “standard” treat-
ments were not excluded); patient immunocompromised
(known regular systemic corticosteroid therapy exceeding
7 mg/kg/day of hydrocortisone or equivalent within 3
months of admission and prior to acute episode, known
regular therapy with other immunosuppressive agents (for
example, azathioprine), known to be HIV-positive or to
have AIDS as defined by the Centers for Disease Control
and Prevention, neutrophil count <1,000/mm3 due to any
cause, including metastatic disease and haematological
malignancies or chemotherapy, but excluding severe
sepsis; organ or bone marrow transplant recipient and
receiving immunosuppressive therapy).
See Additional file 1 for information on database and
quality assurance.
Statistical analysis
Clinical data of patients with FP recruited to GenOSept
were collected on days 1, 2, 3, 5 and 7 of the ICU stay, in-
cluding all variables required to calculate admission Acute
Physiology and Chronic Health Evaluation (APACHE) II
and daily Sequential Organ Failure Assessment (SOFA)
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absence) of acute renal failure (ARF); the study was started
before the international definitions of acute kidney injury
(AKI) had been developed.
Data extracted from the electronic case report form
for the purposes of this analysis pertained to the first
week of ICU admission. The trends were calculated as
linear change over the first week (obtained by subtract-
ing the value on day 1 from the value on day 7) as a pro-
spectively chosen summary measure for the primary
analysis. The use of summary measures to combine data
obtained at multiple time points for the same individual
is a recommended statistical procedure. Use of such a
measure allowed identification of a general trend over
the first week of ICU stay while also avoiding common
pitfalls in the analysis of serial measurements [20].
The primary study outcome was 6-month mortality.
Secondary endpoints were ICU, hospital and 28-day mor-
tality. We also evaluated shorter-term trends by subtract-
ing the values on day 1 from the values on days 2, 3 and 5.
We analysed trends in all 35 variables where data were
available for the first week of ICU stay. For each trend,
Cox proportional hazards (PH) regression analyses
adjusted for age and sex were performed for each end-
point. Trends found to be significant in these analyses,
after Bonferroni correction for multiple testing (P value
<0.00143 = 0.05/35 to take account of the 35 variables
tested), were entered into a multivariate Cox PH model
to identify the factors independently associated with
mortality, adjusting for potential confounding factors.
The full list of variables whose trends were tested is
provided in Additional file 1.
Statistical analyses were performed using R version
2.11.1 (The R Project for Statistical Computing [21]) and
STATA (StataCorp, College Station, TX, USA) [22]
statistical software.
Results
Between 29 September 2005 and 5 January 2011, 977 pa-
tients with a diagnosis of FP confirmed at laparotomy
were recruited into the GenOSept cohort. Their median
age was 69.2 (interquartile range (IQR), 58.3 to 77.1)
years; 54.3% were men; and 98.6% of patients were
Caucasian. The median ICU and hospital lengths of stay
were 10 (IQR, 5 to 21) days and 28 (IQR, 15 to 51) days,
respectively. The median APACHE II score was 16 (IQR,
12 to 21). Of these 977 patients, 187 (19.1%) had died at
28 days, 204 (20.9%) died during their ICU stay, 283
(28.7%) died in the hospital and 309 (31.6%) had died by
the 6-month follow-up examination. Other admission
characteristics of the GenOSept FP cohort were described
in our previous publication [12].
Of 977 patients, 937 patients stayed in the ICU for at
least 2 days; hence, they could be included in the analysisof dynamic trends. Of the remaining 40 (4.1%), 11 died on
day 1, and 29 were discharged alive from the ICU on day
1 (of whom 21 were alive at 6 months and 8 were cen-
sored alive at hospital discharge). Also, 321 individuals did
not have data for day 7, 237 did not have data at day 5 and
107 did not have data at day 3 (either because they had
died or they had been discharged alive from ICU).
Table 1 describes trends in clinical variables between
day 1 and day 7 of the ICU stay; for values related to
days 2, 3 and 5, see Additional file 1: Table S1. During
the observed period, the proportion of patients with
ARF decreased from 29.1% (283 of 974) to 24.1% (159 of
659). The proportion of those receiving ventilatory sup-
port (as continuous positive airway pressure or invasive
mechanical ventilation) fell from 76.3% (743 of 974) to
62.9% (413 of 657). The proportion of those receiving
any inotropic and/or vasopressor therapy decreased
from 72.6% (707 of 974) to 34.2% (226 of 660). The me-
dian (IQR) SOFA score decreased from 7 (5 to 10) to
5 (2 to 8), mainly due to a decrease in the cardiovascular
and renal components.
Table 2 shows the estimated hazard ratios (HRs) for
the primary and secondary endpoints for trends in vari-
ables that were significant after adjusting for multiple
testing in individual variable analyses and after inclusion
in multivariate analyses.
The trends in variables over the first 7 days of the ICU
stay that remained significantly and independently asso-
ciated with 6-month outcome were worsening thrombo-
cytopaenia and renal function (total daily urine output
and renal component of the SOFA score), highest re-
corded level of bilirubin and GCS component of the
SOFA score.
Changes in renal function (total daily urine output and
renal component of the SOFA score), GCS component
of the SOFA score, total SOFA and worsening thrombo-
cytopaenia were also independently associated with sec-
ondary outcomes.
Dynamic trends in all other measured laboratory and
physiological variables and in radiological findings failed
to be independently associated with outcome on multi-
variate analyses. Furthermore, changes in respiratory
support, renal replacement therapy and inotrope and/or
vasopressor requirement appeared not to be independ-
ently associated with any of the primary or secondary
outcomes.
Figure 1 displays trends over the first week of ICU
admission in the five variables independently associated
with 6-month outcome (thrombocytopaenia, daily urin-
ary volume, renal and GCS components of the SOFA
score, serum bilirubin concentration). Survivors and non-
survivors displayed differences in both absolute values and
trends in these variables during their ICU stay. The plate-
let count remained consistently lower throughout the
Table 1 Trends in variables during first 7 days of intensive care unit staya
Day 1 Day 7
Characteristics N n or median % or IQR N n or median % or IQR
Organ failure and support
ARF 974 283 29.1% 659 159 24.1%
RRT 974 115 11.8% 659 104 15.8%
Ventilatory support 974 743 76.3% 657 413 62.9%
Inotrope/vasopressor useb 974 660
None 267 27.4% 434 65.8%
A 33 3.4% 36 5.5%
B 169 17.4% 105 15.9%
C 505 51.9% 85 12.9%
SOFA 974 7 5 to 10 659 5 2 to 8
GCS SOFA 974 0 0 to 1 674 0 0 to 1
CVS SOFA 974 4 1 to 4 671 1 0 to 3
Coagulation SOFA 974 0 0 to 1 674 0 0 to 1
Respiratory SOFA 974 2 2 to 3 659 2 1 to 3
Renal SOFA 974 1 0 to 2 674 0 0 to 1
Bilirubin SOFA 974 0 0 to 1 674 0 0 to 0
Laboratory variables
Serum bicarbonate 893 21 18 to 24 580 26 23 to 29.1
paO2 (kPa) 945 11.3 9.6 to 13.9 590 10.8 9.2 to 13.6
paCO2 (kPa) 938 5.2 4.6 to 6 535 5.2 4.7 to 6
Highest creatinine (μmol/L) 974 106.6 76 to 160 654 81.5 53.9 to 132
Lowest creatinine (μmol/L) 974 100 70 to 144 642 81.5 54 to 130
Highest WCC (10−9/L) 974 12 7.1 to 18 643 15.3 11 to 20.4
Lowest WCC (10−9/L) 974 9.4 4.6 to 15 643 15 10.5 to 20
Lowest platelets (10−9/L) 974 212.5 145 to 300 640 234.5 132 to 352.5
Highest bilirubin (mmol/L) 974 13 8 to 22 650 10 5 to 19
Highest urea (mmol/L) 908 11 6.4 to 17.1 607 11.6 7.2 to 20.8
Chest radiography findings
Localised infiltrates 973 115 11.8% 672 68 10.1%
Lobar infiltrates 973 61 6.3% 672 32 4.8%
Diffuse bilateral infiltrates 973 148 15.2% 672 109 16.2%
Physiological parameters
Highest temperature (°C) 974 37.7 37 to 38.3 656 37.4 37 to 38
Lowest temperature (°C) 974 36.2 35.7 to 36.9 656 36.5 36 to 37
Highest SBP (mmHg) 974 140 125 to 155 655 150 135 to 170
Lowest SBP (mmHg) 972 90 80 to 100 655 108 95 to 120
Highest MAP (mmHg) 972 91 82 to 103 649 98 89 to 110
Lowest MAP (mmHg) 970 62 56 to 70 649 71 63 to 80
Highest heart rate (bpm) 974 117 103 to 130 655 104 90 to 118
Lowest heart rate (bpm) 971 85 73 to 99 655 80 70 to 90
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Table 1 Trends in variables during first 7 days of intensive care unit staya (Continued)
Respiratory rate (breaths/min) 966 18 14 to 24 638 20 16 to 27
Urinary volume (ml/24 hr) 973 1,375 790 to 2,100 644 2,276.5 1,333.5 to 3,411.5
paO2/FiO2 ratio (kPa) 942 27.8 19.6 to 37.7 573 30.7 23.1 to 39.2
aARF, Acute renal failure; bpm, Beats per minute; CVS, Cardiovascular; GCS, Glasgow Coma Scale; IQR, Interquartile range; MAP, Mean arterial pressure; n, Absolute
count; N, Number of non-missing observations; paCO2, Arterial partial pressure of carbon dioxide; paO2, Arterial partial pressure of oxygen; paO2/FiO2, Ratio of
partial pressure of arterial oxygen to fraction of inspired oxygen; RRT, Renal replacement therapy; SBP, Systolic blood pressure; SOFA, Sequential Organ Failure
Assessment; WCC, White cell count. bInotropic and vasopressor use is coded as follows: A = dopamine ≤5 μg/kg/min or dobutamine; B = dopamine >5 μg/kg/min
or adrenaline/noradrenaline ≤0.1 μg/kg/min; C = dopamine >15 μg/kg/min or adrenaline/noradrenaline >0.1 μg/kg/min.
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survivors compared with survivors. The daily total urine
output was consistently greater and increased more mark-
edly in survivors compared with non-survivors through-
out the 7 days (Table 3). The highest measured bilirubin
level showed an improvement during the 7-day observa-
tion period in survivors, but not in non-survivors. The
GCS component of the SOFA score for non-survivors
tended to be initially worse and to deteriorate further dur-
ing the observation period, and the renal component of
the SOFA score tended to be consistently worse in non-
survivors.
The analyses of trends over the first 2, 3 and 5 days
yielded similar results. The trends over the first 48 hours
of the ICU stay independently associated with outcomes
were deteriorating thrombocytopaenia and renal func-
tion (urinary output and renal SOFA score) and total
SOFA score (Additional file 1: Table S2). The trendsTable 2 Factors independently associated with 6-month, inte
adjustment for age and sexa
Variable
6-month mortality
Deterioration of thrombocytopaenia (10 × 10−9/L platelets)
Decrease in daily urinary volume (100 ml)
Decrease in highest recorded bilirubin (mmol/L)
Improvement in GCS SOFA score (1 point)
Improvement in renal SOFA score (1 point)
ICU mortality
Decrease in daily urinary volume (100 ml)
Improvement in total SOFA score (1 point)
Hospital mortality
Deterioration of thrombocytopaenia (10 × 10−9/L platelets)
Decrease in daily urinary volume (100 ml)
Improvement in GCS SOFA score (1 point)
Improvement in renal SOFA score (1 point)
28-day mortality
Decrease in daily urinary volume (100 ml)
Improvement in GCS SOFA score (1 point)
Improvement in renal SOFA score (1 point)
aCI, Confidence interval; GCS, Glasgow Coma Scale; HR, Hazard ratio; ICU, Intensiveover the first 3 days in the ICU independently associated
with outcomes were thrombocytopaenia, renal function
(urinary output and renal SOFA score), total SOFA score
and, for 28-day mortality only, GCS SOFA score, mean
arterial pressure and ratio of partial pressure of arterial
oxygen to fraction of inspired oxygen (Additional file 1:
Table S3). The trends over the first 5 days in the ICU
independently associated with outcomes were thrombo-
cytopaenia, renal function (urinary output, renal SOFA
score and highest recorded serum urea) and total SOFA
score (Additional file 1: Table S4).Discussion
This large, prospectively gathered, diagnostically homo-
geneous and rigorously quality-assured European cohort
provides a unique opportunity to examine associations
between trends in clinical variables and short- and long-nsive care unit, hospital and 28-day mortality, after
HR 95% CI P-value
1.02 1.01 to 1.03 <0.001
1.02 1.01 to 1.03 <0.001
0.99 0.99 to 0.99 0.020
0.81 0.68 to 0.98 0.028
0.87 0.75 to 0.99 0.047
1.02 1.01 to 1.03 0.005
0.91 0.85 to 0.98 0.009
1.02 1.01 to 1.03 0.001
1.02 1.01 to 1.03 <0.001
0.8 0.68 to 0.95 0.011
0.87 0.77 to 0.99 0.043
1.02 1.01 to 1.03 0.001
0.75 0.61 to 0.93 0.010
0.79 0.66 to 0.95 0.013
care unit; SOFA, Sequential Organ Failure Assessment.
Figure 1 Trends in variables independently associated with 6-month survival (primary outcome). (A1) to (A3) Daily lowest platelet count, 24-hour
urinary volume and highest recorded bilirubin concentration. The boxes indicate median and interquartile range (IQR), the whiskers extend to
include 1.5× IQR and the dots include outliers outside this range. (B1) and (B2) Daily Glasgow Coma Scale (GCS) score and renal components
of the Sequential Organ Failure Assessment (SOFA) score. Proportions of different values of the renal and GCS components of the SOFA are
indicated for survivors and non-survivors.
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ted to ICUs.
In our study, the trends most strongly associated with
mortality in all the analyses were worsening thrombo-
cytopaenia and renal dysfunction, SOFA score and, in
particular, the GCS and renal components of the SOFA
score.
In two studies published as conference abstracts,
researchers have specifically evaluated outcomes of crit-
ically ill patients with FP, with different mortality rates
reported [23]. Sayer et al. reported in-hospital mortality
rates of 21.6% and 38.1% for the malignancy and non-
malignancy subgroups, respectively [23,24], whereas
Pawa et al. reported 30-day mortality rates of 46% for
patients aged <75 years and 78% for patients aged >75
years, suggesting that different local practices of critical
care admission, periods considered, evolution in concur-
rent treatments and underlying characteristics of the
populations (other than admission diagnosis) may have
influenced their results. None of the studies involvedmicrobiological isolates or the relationship between trends
in clinical variables and outcomes. Pawa and coworkers
reported age as the strongest outcome predictor, whereas
Sayer and colleagues suggested that hypoalbuminaemia
and the presence of malignancy influence mortality [24].
In other studies, researchers have evaluated heterogeneous
populations of patients with peritonitis of multiple aetiol-
ogies, with several different predictors identified, depend-
ing on the patient case mix [9,25,26].
Worsening thrombocytopaenia
In our cohort, worsening thrombocytopaenia over the
first 7 days of the ICU stay was found to be independ-
ently associated with the primary outcome (6-month
mortality) and two of the secondary outcomes (hospital
and 28-day mortality). Thrombocytopaenia is a common
finding following operative intervention for intraab-
dominal sepsis, and a falling platelet count has been
reported to be useful for distinguishing infected from
non-infectious peritonitis [27]. Thrombocytopaenia is
Table 3 Trends during first 7 days of the intensive care unit stay (in survivors and non-survivors at 6 months) for
variables independently associated with outcomes in multivariate analysesa
Day 1 Day 7
Characteristics N Median IQR N Median IQR
Lowest platelets (*109/L)
Survivors 667 226 159 to 316 426 267 164 to 388
Non-survivors 307 185 113 to 280 214 146 78 to 274
Urinary volume (ml/24 hours)
Survivors 666 1,499 916 to 2,170 429 2460 1,680 to 3,633
Non-survivors 307 1,080 475 to 1,915 215 1750 471 to 2,774
Highest bilirubin (mmol/L)
Survivors 667 13 8 to 21 433 9 5 to 17
Non-survivors 307 14 8 to 25 217 14 6 to 25
GCS SOFA score
Survivors 667 0 0 to 0 453 0 0 to 0
Non-survivors 307 0 0 to 2 221 1 0 to 2
Renal SOFA score
Survivors 667 0 0 to 1 453 0 0 to 1
Non-survivors 307 1 0 to 3 221 1 0 to 3
aGCS, Glasgow Coma Scale; IQR, Interquartile range; n, Absolute count; N, Number of non-missing observations; SOFA, Sequential Organ Failure Assessment.
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products and development of consumption coagulopathy.
A strong link between poor outcome of critically ill patients
and both low absolute platelet counts and the development
and/or worsening of thrombocytopaenia have also previ-
ously been reported in various patient populations [28-32].
In the study by Vanderschueren and colleagues, who stud-
ied an unselected population of intensive care patients, the
development of thrombocytopaenia and a reduction from
baseline of 50% or more in platelet count had more ex-
planatory power for ICU mortality than admission variables
[28]. Williamson et al. examined the effects of prevalent
and incident thrombocytopaenia in an unselected popula-
tion of over 20,000 critically ill patients and demonstrated
an independent association of low platelet counts with
mortality. This association was stronger for specific admis-
sion diagnoses, in particular the cancer, respiratory, digest-
ive, genitourinary and infectious categories [29]. In the
study by Strauss et al., a decrease in platelet count ≥30%
was significantly linked to higher mortality in 145 unse-
lected critically ill patients [30]. Sharma et al., in a prospect-
ive observational study, evaluated the incidence of various
degrees of severity of thrombocytopaenia in 69 patients
with septic shock and concluded that thrombocytopaenia is
associated with worse clinical outcomes in their unselected
population of critically ill patients [31]. Crowther et al. also
found that the development of thrombocytopaenia was
strongly associated with mortality in 261 unselected critical
care patients [32].Deteriorating renal function
In the GenOSept FP cohort, worsening renal function
was consistently found to be associated with higher mor-
tality at all time points. Although there is still some
debate as to whether the excess mortality observed with
renal dysfunction simply reflects the severity of the
underlying illness or whether renal dysfunction inde-
pendently contributes to poorer survival, the retention
of this relationship on multivariate analysis suggests that
the development of AKI directly contributes to worse
outcomes. Impaired renal function has also been linked
to impaired immune function [33-36]. In the study by
Barrantes et al. of 496 critically ill patients, the mortality
rate of patients with AKI was significantly higher than
those without [33]. Ostermann et al. examined the effect
of AKI on over 22,000 adult general ICU patients and
found that the AKI classification correlated with out-
come [34]. In a study conducted in an unselected ICU
population of almost 42,000 patients, the same authors
examined the criteria for acute renal injury, acute renal
failure syndrome and severe acute renal failure syndrome
and found that worsening degrees of renal impairment
correlated with mortality [35]. Mehta et al. studied 611
unselected ICU patients and highlighted the higher
incidence of sepsis amongst those with AKI [36].
Deteriorating Sequential Organ Failure Assessment score
Although the SOFA score was originally conceived as a
tool for describing the evolution of dysfunction in various
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trends in the global SOFA score and in specific compo-
nents (renal and GCS) were closely associated with mor-
tality [19]. Our findings are comparable with those of a
recently reported prospective observational cohort study
in which the researchers investigated the systems that
most contribute to the development of multiple organ
system failure (MOSF). That study of 102 patients with
abdominal sepsis highlighted the importance of trends in
the SOFA score, demonstrating how the value on day 4
(as opposed to admission SOFA) had a high precision in
predicting 28-day mortality, with MOSF being contributed
to mainly by renal, central nervous system and respiratory
system dysfunction [5]. In another study, which included
62 critically ill patients with postoperative peritonitis, in-
vestigators demonstrated the importance of trends in
SOFA scores calculated serially over a 5-day postopera-
tive period to distinguish between patients with or with-
out persistent postoperative intraabdominal sepsis [6].
In a prospective observational study of 56 patients with
secondary peritonitis, researchers measured several
inflammatory parameters and multiple severity scoring
systems preoperatively and over a 5-day postoperative
period in a serial fashion. That study showed that
combining the SOFA scores with measurement of
serum neopterin concentration (a specific cellular
immune system activation marker) and tumour necrosis
factor receptor 2 levels yielded the highest predictive
sensitivities and specificities for pre- and postoperative
outcomes [7]. In a study of 163 consecutive ICU
patients with secondary peritonitis, hospital mortality
was accurately predicted by the postoperative SOFA
score [8]. In a large trial comparing on-demand versus
planned relaparotomy for severe peritonitis, the SOFA
score showed good discriminatory power to predict
hospital mortality, although it was unable to predict the
need for relaparotomy [9,37]. In a retrospective cohort
study by Sumi et al., both the SOFA score and Physiological
and Operative Severity Score for the enUmeration of
Mortality and Morbidity were able to stratify patients’
risk for undergoing surgical intervention for colorectal
perforation [38].
Mulier et al. also previously reported the influence of
coma on mortality in a study of generalized postopera-
tive patients with peritonitis independently of age and
source control [39]. Similarly, Matsumura et al. studied
218 general medical and surgical ICU patients and
showed that serum procalcitonin levels and SOFA score
at ICU discharge could predict post-ICU mortality and
survival time [40]. Jones et al. studied 248 emergency
department patients with severe sepsis and evidence of
hypoperfusion at presentation, and they concluded that
the SOFA score had prognostic value for in-hospital
survival [41].Hyperbilirubinaemia
Postoperative hyperbilirubinaemia has been linked to
persistent postsurgical infection and a poor prognosis
[42]. In a study of patients with peritonitis, hyperbiliru-
binaemia, together with age and organ and/or system
failures, was found to be amongst a number of mortality
predictors in univariate analysis [43].
Although the HRs presented above in Table 2 are
small, the larger the change in the underlying variable,
the larger the effect (proportionally) on mortality. For
example, a reduction in platelet count of 50 (*109/L) is
associated with a HR for 6-month mortality of 1.10 (95%
confidence interval (CI), 1.05 to 1.16; P <0.001), indicat-
ing a 10% increase in risk of death at 6 months. Simi-
larly, a reduction in 24 hour urine output of just 500 ml
is associated with a HR for 6 month mortality of 1.09
(95% CI, 1.04 to 1.14; P <0.001), which translates into a
9% increase in risk of death. Such trends are therefore
potentially relevant to the practicing clinician and will
contribute to bedside assessment of severity of illness in
patients with FP.
Limitations
The main limitation of our study is the potential for
unmeasured factors to confound the associations detec-
ted. Subsequent prospective studies specifically aimed
at confirming the potential predictive accuracy of the
trends identified here are required to further assess their
value in clinical practice. The overwhelming majority of
patients enrolled in this study were Caucasian; therefore,
caution should be exercised when extrapolating these
findings to different ethnic populations. Our findings are
applicable to patients with FP who stayed in the ICU for
at least 2 days, although only 40 (4.1%) of the 977 patients
with FP in this cohort had a shorter stay; hence, we
consider it unlikely that this generated significant bias.
Conclusions
In this large and homogeneous cohort of critically ill
patients with FP admitted to European ICUs, we have
shown that changes in routinely measured clinical,
physiological and laboratory parameters, readily available
at the bedside, are associated with outcome. Only deteri-
oration in renal function, thrombocytopaenia and SOFA
score over the first 2, 3, 5 and 7 days were consistently
associated with mortality. Other laboratory variables,
radiological findings, physiological parameters or even
changes in respiratory support, renal replacement
therapy and inotrope and/or vasopressor requirements,
as analysed here over multiple time intervals, appeared
not to be independently and consistently associated with
any of the primary or secondary outcomes.
Patients displaying deteriorating trends in these key
clinical variables may be prospectively identified as at
Tridente et al. Critical Care  (2015) 19:210 Page 9 of 10higher mortality risk. External validation of the predict-
ive power of the trends identified here would clarify to
what extent detection of such trends could be relied
upon to inform clinical decision making.
Key messages
 In critically ill patients with faecal peritonitis, only
deterioration in renal function, thrombocytopaenia
and SOFA score over the first 2, 3, 5 and 7 days
were consistently associated with mortality.
 Other laboratory variables, radiological findings,
physiological parameters or changes in respiratory
support, renal replacement therapy and inotrope
and/or vasopressor requirements were not
independently associated with any of the primary
or secondary outcomes.
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